Ibrahim, Raihan .
HRN: 08-39-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
CEFUROXIME 750MG (VIAL)
10/25/2023
11/01/2023
IV
750mg
TID
Age; Dengue Fever
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes